# OnCo record paper-yu-anti-gd2-neuroblastoma-nejm-2010 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-yu-anti-gd2-neuroblastoma-nejm-2010/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-yu-anti-gd2-neuroblastoma-nejm-2010" ;
  schema:name "Anti-GD2 antibody with GM-CSF, interleukin-2 and isotretinoin for high-risk neuroblastoma (COG ANBL0032)"@en ;
  schema:description "Adding the anti-GD2 antibody ch14.18 with cytokines to isotretinoin after transplant improved two-year event-free survival in high-risk neuroblastoma from 46 to 66 percent, making immunotherapy a standard part of treatment."@en ;
  schema:url <https://onco.cc/key-papers/paper-yu-anti-gd2-neuroblastoma-nejm-2010/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa0911123>, <https://pubmed.ncbi.nlm.nih.gov/20879881/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa0911123> ;
  schema:datePublished "2010"^^xsd:gYear ;
  schema:author "Yu AL, Gilman AL, Ozkaynak MF, et al." ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma-high-risk/> ;
  onco:journals <https://onco.cc/journals/nejm/> .